Illumina director reports sale of 1,500 shares
Illumina-related reporting person reported a sale of 1,500 shares of common stock on 05/28/2026 under a 10b5-1 plan, generating $225,150 in proceeds.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Illumina-related reporting person reported a sale of 1,500 shares of common stock on 05/28/2026 under a 10b5-1 plan, generating $225,150 in proceeds. The filing also lists 478 Restricted Stock Units and an Employee Stock Purchase Plan allocation of 500 shares.
Insights
Routine, pre-arranged insider sale disclosed under Section 144/10b5-1.
This filing shows a reported disposition of 1,500 shares on 05/28/2026 with proceeds of $225,150. The sale is described as executed pursuant to a 10b5-1 plan, indicating pre-arranged timing.
The cashflow treatment is attributable to the reporting person; remaining holdings include 478 RSUs and an ESPP allocation of 500 shares as listed. Timing and broader position context are limited to the excerpt; subsequent filings would show further position changes.
Key Figures
Key Terms
10b5-1 regulatory
Restricted Stock Units financial
Employee Stock Purchase Plan financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did the ILMN filing disclose about insider sales?
Who executed the 10b5-1 sales reported in the ILMN excerpt?
Does the filing show other securities held by the reporting person?
Was the insider sale described as pre-arranged or discretionary?
AI-generated analysis. How Rhea-AI works. Not financial advice.